Change in plasma membrane Ca2+-ATPase splice-variant expression in response to a rise in intracellular Ca2+  by Zacharias, David A. & Strehler, Emanuel E.
1642 Research Paper
Change in plasma membrane Ca2+-ATPase splice-variant
expression in response to a rise in intracellular Ca2+
David A. Zacharias and Emanuel E. Strehler
Background: Most eukaryotic genes are divided into introns and exons. Upon
transcription, the intronic segments are eliminated and the exonic sequences
spliced together through a series of complex processing events. Alternative
splicing refers to the optional inclusion or exclusion of specific exons in
transcripts derived from a single gene, which leads to structural and functional
changes in the encoded proteins. Although many components of the machinery
directing the physical excision of introns and joining of exons have been
elucidated in recent years, the signaling pathways regulating the activity of the
machinery remain largely unexplored. 
Results: A calcium-mediated signaling pathway regulates alternative splicing at a
specific site of human plasma membrane calcium pump-2 transcripts. This site
consists of three exons, which are differentially used in a tissue-specific manner.
In IMR32 neuroblastoma cells, a transient elevation of intracellular calcium
changed the predominant pattern from one in which all three exons are included
to the coexpression of a variant including only the third exon. Western-blot
analysis demonstrated that the newly expressed mRNAs are faithfully translated.
Once induced, the new splicing pattern was maintained over multiple cell
divisions. Protein synthesis was not required to induce the alternative splice
change, indicating that all components necessary for a rapid cellular response
are present in the cells. 
Conclusions: Calcium signaling exerts a direct influence on the regulation of
alternative splicing. Notably, a calcium-mediated change in the expression of
alternatively spliced variants of a calcium regulatory protein was discovered. The
change in splicing occurs quickly, is persistent but reversible and leads to a
corresponding change in protein expression. The specific nature in which
differently spliced protein variants are expressed, and now the fact that their
expression can be regulated by distinct intracellular signaling pathways,
suggests that the regulation of alternative splicing by physiological stimuli is a
widespread regulatory mechanism by which a cell may coordinate its responses
to environmental cues. 
Background
Alternative mRNA splicing is a common mechanism by
which metazoan organisms regulate gene expression. Pre-
mRNA molecules are composed of exons, regions which
are retained in the mature mRNA and comprise the
sequences that specify the amino-acid sequence of the
final protein product, and intervening sequences (introns)
of varying lengths which are excised from the pre-mRNA
[1,2]. There are many examples of development-specific,
sex-specific and tissue-specific splicing events which
restrict the expression of certain proteins to a particular
time or to a specific cell or tissue within an organism.
Perhaps the most striking example is the Drosophila sex-
determination pathway, which involves an amazing
cascade of regulated alternative splicing events culminat-
ing in the determination of gender in the fly [3,4]. Much
has been learned about the components of the spliceo-
some which coordinate and execute the two-step process
of intron removal and exon fusion [1,4–7]. The spliceo-
some is composed primarily of five small nuclear RNAs
(snRNAs) which are bound to proteins and named small
nuclear ribonucleoprotein particles (snRNPs). A large
number of regulatory SR proteins (so named because they
contain serine/arginine-rich motifs) interact transiently
with the spliceosomal assembly during multiple steps of
the splicing event and regulate alternative splicing (for a
recent review, see [8]). Their tasks include the mobiliza-
tion of the spliceosomal snRNPs to the pre-mRNA and
directing the interactions between the components of the
spliceosome — thereby specifying splice sites and defin-
ing exons and introns. A synopsis of the current state of
knowledge and recent developments in the fields of the
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biochemistry and regulation of alternative splicing has
recently appeared in the literature [7].
Differential regulation of alternative splicing may occur
because members of the SR protein family have a
restricted tissue or cell-type distribution. The many exam-
ples of splicing events specific to a particular tissue or cell
type (for example, muscles and nerves [9–11]) have led to
the hypothesis of the existence of cell- or tissue-specific
splicing factors. Black and colleagues [12] recently
described a neuron-specific 75 kDa protein which is a
unique member of a complex composed primarily of con-
stitutive spliceosomal proteins. This protein appears to be
at least partially responsible for inducing the assembly of
constitutive regulatory proteins in a manner leading to the
inclusion of the neuron-specific exon N1 in src mRNA.
Outside of this example, little is known about the identity
of specifically localized splicing factors. However,
although some constitutive SR proteins are not cell-type
specific, their relative abundance from cell to cell may
differ resulting in a variation of the splicing pattern of
some mRNAs [13–15]. Alternative splicing is also influ-
enced by factors such as the peptide hormone insulin [16],
contractile activity in muscle [17] and electrical activity in
the brain [18]. In some of these cases, changes in the
expression of alternative splice variants have been linked
to the activation of certain signaling pathways within a
cell, but in no case has any splicing event been shown to
be directly and immediately regulated by those signaling
pathways in a manner that bypasses the need for new
protein synthesis.
Calcium is one of the most widespread and important
second messengers in eukaryotic cells [19]. Neuronal
events in which the precise regulation of calcium is criti-
cal are diverse, ranging from excitotoxic cell death and
neurodegeneration to higher-order brain functions such
as long-term potentiation (LTP) and long-term depres-
sion (LTD), two forms of neuronal plasticity thought to
provide the physiological basis for learning and memory.
The level of free calcium within a cell therefore needs to
be tightly regulated both spatially and temporally. One of
the key components of the calcium regulatory machinery
is the plasma membrane calcium ATPase (PMCA) [20].
This calcium-specific pump represents the sole high-
affinity calcium extrusion system found in all eukaryotic
cells, and its proper function is critical to the preservation
of calcium-related signaling integrity. The human PMCA
(hPMCA) gene family comprises four members whose
primary transcripts are alternatively spliced at two major
sites, one near the 5′ end (named site A), the other near
the 3′ end (site C) [21] (Fig. 1). Alternative splice variant
expression of the PMCA mRNAs is both developmentally
[22] and tissue-specifically regulated [23–26], with the
highest diversity in the brain [23,25,27]. In an attempt to
understand the mechanisms behind the regulated
expression of PMCA splice variants, we chose a neuron-
like cell type, the IMR32 human neuroblastoma line
[28], in which we perturbed the level of intracellular
calcium and assayed the expression of alternative splice
variants at each splice site in each of the hPMCA genes.
We found that splicing at site A of hPMCA2 was altered
directly in response to a calcium-mediated second mes-
senger signaling pathway. The change in alternative
splicing occurred rapidly, was not dependent on new
protein synthesis, and was persistent over multiple cell
divisions. This example of a signaling-induced rapid
change in alternative mRNA splicing may represent a
general post-transcriptional mechanism enabling cells to
respond quickly to calcium-related stimuli with long-
lasting, albeit reversible consequences.
Results
IMR32 human neuroblastoma cells express a specific subset
of alternative splice variants from all four hPMCA genes 
Before attempting to investigate the effects of a rise in
intracellular free calcium on alternative PMCA splicing, we
determined the pattern of expression of the PMCA genes
and their splice products in IMR32 human neuroblastoma
cells grown under standard growth conditions. Reverse
transcriptase-polymerase chain reaction (RT-PCR) experi-
ments using gene-specific primers flanking the two alter-
native splice sites A and C of the PMCA genes established
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Figure 1
(a) Linear representation of a PMCA with its main structural and
regulatory domains. The two major sites A and C where alternative
splicing leads to isoform diversity are indicated. The ten putative
transmembrane domains (TM) are numbered, and major structural and
regulatory domains are indicated as: I-CaM, region of autoinhibitory
interaction with the calmodulin-binding domain; PL, acidic
phospholipid-sensitive region; P, site of the formation of the aspartyl-
phosphate intermediate during the reaction cycle; F, FITC-sensitive site
(part of the ATP-binding domain); CaM, calmodulin-binding domain.
(b) Expanded view of splice site A in the hPMCA2 gene to illustrate
the exon arrangement in each of the alternative splice variants (w and
x) discussed in this paper. The sizes of the alternatively spliced exons
are given in nucleotides (nt); C refers to constitutively spliced exons.
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that IMR32 cells express all four PMCA genes, and identi-
fied the precise pattern of alternative splicing at each of
the sites for each of the PMCA genes (Fig. 2). With the
exception of PMCA3, splice site C, where two splice forms
(the a and the b variants) were expressed at approximately
equal levels, only a single major splice product was
detected at each site of each of the PMCA transcripts in
the IMR32 cells.
A transient rise in intracellular free calcium regulates
alternative splicing of hPMCA2 at site A in IMR32 cells
Intracellular calcium may be elevated in cells by a number
of different mechanisms. To analyze the effects of an
increase in calcium on alternative mRNA splicing of
hPMCA transcripts in IMR32 cells, we chose to elevate
intracellular calcium primarily by the activation of voltage-
gated calcium channels in the plasma membrane. This was
accomplished by depolarizing the cells with high levels
(56 mM) of K+ iso-osmotically exchanged for Na+ in the
medium (see Materials and methods). The pattern of
PMCA alternatively spliced mRNA expression was then
analyzed by RT–PCR as described above. This treatment
resulted in a specific change in the expression pattern of
alternative splice variants of hPMCA2 at site A (Fig. 2a). In
non-perturbed IMR32 cells, only the w splice variant (all
exons included; see Fig. 1) was expressed at site A of
hPMCA2 (Fig. 2a). Following a calcium transient, the x
splice variant (first two exons removed; see Fig. 1) was
expressed concomitantly with w. No other splice site in
any of the other PMCA genes was affected by this treat-
ment (Fig. 2a,b). The K+ pulse time required to induce the
observed change in alternative splice variant expression
was as short as 1 minute. As shown in Figure 3a, pulse
times ranging from 1 minute to 1 hour consistently
induced the shift in alternative splice variant expression.
Extending the incubation times in high KCl medium to
several hours (up to overnight) had no different outcome
— both the w and the x splice forms of PMCA2 mRNA
continued to be about equally abundant. The new (x)
splice form appeared gradually and could be detected
between 30–45 minutes following the onset of depolariza-
tion (data not shown). Interestingly, however, expression
of the x splice form never appeared to exceed that of the w
form. Because of rapid inactivation of the N-type voltage-
gated calcium channels which predominate in IMR32 cells
[29,30], the maximal elevation of calcium induced by high-
KCl depolarization is concluded in less than 2 minutes.
This was shown by imaging the cytoplasmic Ca2+ concen-
tration ([Ca2+]i) in fluo-3-loaded IMR32 cells (Fig. 3b, left
panel). We monitored [Ca2+]i in cells exposed to 56 mM
KCl for up to 30 minutes, and found that a slightly higher
level was maintained for the duration of the exposure (Fig.
3b, right panel). Thus, with continued exposure to high
KCl, the cells adjust their resting internal calcium levels to
a new set-point, slightly above that found in cells prior to
depolarization. The initial decrease in fluo-3 signal inten-
sity was a function of calcium channel inactivation and
reequilibration of [Ca2+]i by the cellular homeostatic
machinery, rather than an artifactual bleaching of the
signal caused by exposure to the laser light. This is illus-
trated by the fact that the addition of 10–6 M of the
calcium ionophore 4-bromo-A23187 was still able to cause
a large increase in [Ca2+]i (Fig.3b, right panel).
Once induced, the shift in alternative splicing is long-lasting 
We next assayed the shift in alternative splicing in IMR32
cells at various timepoints following a depolarizing pulse
of KCl and subsequent recovery in serum-free control
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Figure 2
KCl-depolarization of IMR32 cells alters splice
variant expression only at site A of hPMCA2.
IMR32 cells were either continuously grown in
standard medium or depolarized by a 3 h pulse
in medium containing 56 mM KCl, and the
expression pattern of the splice variants for all
hPMCAs was then assayed at site A (a) and C
(b) by RT–PCR. The original pattern of splice
variants was maintained at all splice sites except
at site A of hPMCA2 where depolarization led
to the additional appearance of the faster
migrating x variant. Splice variants expressed at
site A were: hPMCA1, x; hPMCA2, w and x;
hPMCA3, x; hPMCA4, x. At site C, no changes
in alternative splicing occurred upon
depolarization, and the following splice variants
were expressed: hPMCA1, a (with traces of c
and d); hPMCA2, b; hPMCA3, a and b;
hPMCA4, b. See [27] for a detailed description
of primers, RT–PCR product sizes, and the
splice variant nomenclature. Diffuse faster-
migrating bands seen in some lanes correspond
to PCR artefacts due to primer dimer formation. 
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–            + –           + –           + –           +KCI depolarization:
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MEM medium. After a 3 hour stimulus in 56 mM KCl, the
w and x splice variants of PMCA2 mRNA continued to be
coexpressed for at least 24 hours in cells returned to
control medium (Fig. 4). Within this period, the majority
of cells did not have time to undergo cell division; hence,
the w and x splice forms were expressed continually in the
cells originally stimulated by high KCl. Cells stimulated
by KCl depolarization for a period of 3 hours followed by
an overnight recovery in serum-free control MEM were
then split 1:10 and plated in MEM containing serum.
Upon confluence, the cells were again assayed for the
expression of splice variants at site A of PMCA2 and,
remarkably, the expression of the x splice form still per-
sisted. This protocol of subculture was continued for 17
passages during which time the expression of splice
variant x was maintained, although it apparently decreased
(Fig. 4, lane p17) and was absent by the 20th passage. 
The change in alternative splicing is dependent on calcium
To determine whether a calcium transient was necessary
to induce the change in splice variant expression, we used
the membrane permeant calcium chelator BAPTA-AM to
effectively eliminate the rise in free cytosolic calcium
resulting from KCl depolarization. When cells were prein-
cubated in 5 mM BAPTA-AM for 30 minutes and then
stimulated by a 15 minute pulse of KCl depolarization, the
change in alternative splicing did not occur (Fig. 5a) and
the calcium transient was suppressed (Fig. 5b). These
findings demonstrate that calcium is the critical compo-
nent at the head of a signaling cascade which culminates
in a specific change in alternative splicing of hPMCA2
transcripts.
The shift in alternative splicing can also be elicited by
calcium from intracellular stores
To investigate whether the specific change in alternative
splicing of hPMCA2 mRNA could also be induced by
calcium derived mainly from intracellular stores, IMR32
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Figure 3
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KCl-depolarization induces a rapid calcium transient and a change in
alternative splice variant expression at site A of hPMCA2. (a) IMR32 cells
were exposed to medium containing 56 mM KCl for the indicated pulse
times and then allowed to recover in standard MEM for the balance of 4 h.
Alternative splicing at site A of hPMCA2 was then assayed by RT–PCR. A
pulse as short as 1 minute induces IMR32 cells to express both the w and x
splice variants concomitantly. The MEM-only control (left lane) illustrates the
steady-state expression of the w splice variant in the absence of any
depolarizing pulse. (b,c) Confocal calcium imaging of fluo-3-AM-loaded
IMR32 cells. (b) K+ depolarization induces a transient rise in intracellular
calcium which peaks and returns to a level just above the previous baseline
within 3 min. (c) Addition of the calcium ionophore 4-bromo-A23187 to cells
kept in high-KCl medium for 30 min, indicates that the short laser exposure
times during the 30 min experiment did not bleach the cells.
Figure 4
The change in alternative splicing is persistent. IMR32 cells were kept in
normal MEM (left lane, control) or depolarized for 3 h in medium
containing 56 mM KCl and then allowed to recover in normal MEM for 0 h,
12 h and 24 h. RT-PCR shows that the change in splicing is maintained in
the cells up to 24 h — before a majority has divided. Other identically
stimulated cells were allowed to recover overnight, then split (subcultured)
and periodically monitored for the expression of alternative splice variants.
Expression of the x variant was still detectable after 17 passages (p17). 
w
x
MEM 0 12
Recovery (h)
24 p17
1646 Current Biology 1996, Vol 6 No 12
cells were incubated for 6 hours in the presence of
1–10 mM thapsigargin, an inhibitor of the endoplasmic
reticulum calcium ATPase. As shown in Figure 6, this treat-
ment resulted in the same change of alternative splicing of
hPMCA2 site A variants as was observed with KCl depolar-
ization. This result further underlines the importance of a
rise in intracellular calcium as the initial signal that triggers
the change in the mode of alternative splicing.
The change in alternative splicing is independent of new
protein synthesis
The rapidity with which the change in expression of alter-
natively spliced PMCA2 mRNA products occurred sug-
gested that a second messenger-dependent signaling
pathway was directly responsible for the observed event.
Preincubation of IMR32 cells for 30 minutes in 50 mg ml–1
cycloheximide, a potent inhibitor of protein translation,
was unable to prevent the KCl depolarization-induced
change in alternative splicing of hPMCA2 transcripts (Fig.
7). To confirm that translation was effectively inhibited
under the conditions used, we metabolically labeled newly
synthesized protein with 35S-methionine in parallel IMR32
cell cultures in the presence or absence of cycloheximide.
Newly synthesized protein was reduced by greater than 99
% in the cell cultures preincubated in cycloheximide when
compared with the control cultures (data not shown).
These experiments indicate that new protein synthesis is
not required for the shift in alternative splicing, and
suggest that a calcium signaling-induced pathway directly
influences the splicing machinery in the nucleus. 
Quantitation of the change in the expression of
alternatively spliced mRNAs by ribonuclease protection
assay (RPA)
RT–PCR is a method for the analysis of gene expression
that relies upon the logarithmic amplification of small
amounts of target cDNA templates. As applied in the
experiments described above, this technology allowed us
to make only qualitative statements about the change in
the expression of alternatively spliced PMCA2 mRNAs —
either a splice variant was detected, or it was not. By
Figure 5
BAPTA-AM blocks the K+ depolarization-
induced change in alternative splicing. (a)
Incubation of IMR32 cells in BAPTA-AM
(5 mM) for 30 min prior to stimulation for
15 min in medium containing 56 mM KCl
blocked the change in alternative splicing
(BAPTA-AM/KCl, right lane). Appropriate
carrier-only (DMSO) controls produced no
change in splice variant expression (MEM, left
lane), whereas high-KCl stimulation without
BAPTA-AM induced the characteristic splice
shift (KCl, middle lane). (b) Intracellular
calcium measurements taken from IMR32
cells loaded with fluo-3-AM and BAPTA-AM
illustrate that BAPTA-AM effectively blocked
the large calcium transient normally induced
by application of 56 mM K+ (arrow indicates
time of addition of high-KCl medium).
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Figure 6
The shift in alternative splicing can also be elicited by calcium from
intracellular stores. Thapsigargin, a potent inhibitor of the
sarco/endoplasmic reticulum calcium ATPase elevates intracellular
calcium levels by blocking re-uptake into intracellular stores. When
IMR32 cells were treated with 5 mM thapsigargin for 6 h, there was a
change in the splice variant expression equal to that observed by KCl
depolarization (Thapsigargin, right lane). Appropriate carrier (ethanol)-
only controls did not produce the change in splice variant expression
(MEM, left lane).
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contrast, ribonuclease protection assays (RPAs) can
provide a direct measurement of the quantity of a given
mRNA present in a sample. To confirm that the change in
alternative splice variant expression detected by RT–PCR
was not a methodology-induced artefact, and/or the
appearance of a new alternative splice product a quantita-
tively minor effect, we probed for the existence of each
hPMCA2 mRNA species independently by RPA. In this
experiment, 32P-labeled, single-stranded antisense probes
were hybridized to 10 mg of whole RNA extracted from
control IMR32 cells or from cells incubated in high KCl
for 3 hours. An antisense probe to glyceraldehyde-3phos-
phate dehydrogenase (GAPDH) was used as a standard to
which levels of the specifically targeted PMCA2 mRNAs
could be compared. The other probes were complemen-
tary to either the w or the x splice variant of hPMCA2 (see
Materials and methods). In full agreement with the
RT–PCR experiments, the RPA data showed that stimu-
lation of IMR32 cells by high KCl induced the additional
expression of the x splice variant (Fig. 8a). Moreover,
these results also showed that the two splice forms were
now present in approximately equal amounts (Fig. 8b).
Additionally, the total level of hPMCA2 message was
increased by almost four-fold (Fig. 8b). 
Western-blot analysis confirms that the alternatively
spliced mRNAs are translated
Total protein was extracted from IMR32 cells grown in
control MEM or from cells stimulated overnight in high-
KCl medium. Total protein in equal quantities per lane
was separated electrophoretically on a 6 % SDS–polyacry-
lamide gel, transblotted onto a polyvinylidene difluoride
(PVDF) membrane, and the membrane probed with a
polyclonal rabbit antibody specific for PMCA2 (see Mate-
rials and methods). Enhanced chemiluminescence detec-
tion was used to visualize the presence of hPMCA2 on
film, which was then quantitatively analyzed as described
in Materials and methods. Because the full-length
hPMCA2w and the hPMCA2x isoforms differ in size by
only 31 amino acids (encoded by the alternatively spliced
exons at site A), corresponding to about 3 kDa in molecu-
lar mass, visual resolution of the two isoforms as distinct
bands on a western blot was difficult, although a broader
band was seen with the protein from the high-KCl stimu-
lated cells than with that from the control cells (Fig. 9a).
However, by computer-assisted analysis of the intensity of
the hPMCA2-specific signal recorded by the film, we were
able to discriminate the two proteins translated from the w
and x splice variant mRNAs (Fig. 9b). The intensity of the
bands in the lanes representing the expression of
hPMCA2 in the treated versus the untreated cells also
showed an increase in the level of protein expression, in
agreement with the increase in the level of mRNA
detected by quantitative RPA. Thus, this experiment
illustrates that both the w and the newly generated x
splice variant mRNAs are translated into proteins, and that
their level of expression is reflected faithfully at the level
of the proteins.
Discussion
In this paper, we provide evidence that alternative mRNA
splicing of the transcripts encoding hPMCA2, a membrane
protein responsible for high-affinity calcium extrusion, is
regulated directly by a calcium-mediated signaling
pathway. After increasing intracellular calcium levels in
IMR32 human neuroblastoma cells, we analyzed alterna-
tive splicing at the two major splicing hotspots (called sites
A and C) in all four PMCA genes, and found that a single,
specific site (site A) of hPMCA2 was affected by this treat-
ment. The change in splicing occurred rapidly and was
persistent, lasting over many cell divisions. Importantly,
we showed that protein synthesis was not necessary for
the change in splicing to occur. These findings are novel
in that they demonstrate that all components required to
redirect the pattern of alternative mRNA splicing, at least
of hPMCA2 transcripts, are present in the IMR32 cells and
may immediately be acted on by signaling pathways.
Western-blot data also showed that both the pre-existing
Figure 7
The initial change in alternative splice variant expression is not
dependent on new protein synthesis. The change in alternative splice
variant expression could not be blocked when IMR32 cells were
preincubated for 30 min in MEM containing 50 mg ml–1 cycloheximide
followed by a 6 h pulse of K+ depolarization (in the continuous
presence of 50 mg ml–1 cycloheximide) (right lane). This indicates that
all the signaling components necessary to cause a change in
alternative splice variant expression are present in IMR32 cells and
may be acted on immediately and directly to cause a change in
splicing of hPMCA2 transcripts at site A. Cells kept in normal MEM do
not show the alternative splice shift (MEM, left lane).
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and the newly generated alternatively spliced mRNAs are
efficiently translated into proteins. 
Historically, synaptosomal preparations from mammalian
brain have been one of the richest sources of purified
PMCA [31–34]. The discovery of the abundance of the
calcium extrusion pump in this location was due in part to
a concerted effort by several groups [32,35,36] to identify
mechanisms that may modify synapses and their compo-
nents as a function of use, a phenomenon commonly
referred to as synaptic plasticity. Subsequently, the gene
family encoding the PMCA isoforms was characterized
and the expression patterns of their mRNAs were ana-
lyzed by in situ hybridization and RT–PCR
[21,22,25,37–39]. Recently, antibodies recognizing specific
isoforms of PMCA have been developed and descriptions
of the tissue distribution and cellular localization of the
corresponding PMCA proteins are beginning to appear in
the literature [40–42]. An interesting finding arising from
these studies is the recent evidence that PMCA2 is
expressed almost exclusively in the brain and displays the
highest level of expression in the dendrites and dendritic
spines of cerebellar Purkinje cells [38,41,43,44]. Dendritic
spines are able to orchestrate localized calcium-mediated
signaling events, and also represent sites of paramount
importance for the phenomenon of synaptic plasticity
[45–48]. Given the rapidity of the calcium signaling-
induced change in splice variant expression of hPMCA2
— which itself is a critical calcium regulatory protein local-
ized within the Purkinje cell dendritic membrane — this
form of regulation of gene expression may represent a
novel mechanism by which cells implement use-depen-
dent alterations in their functionality. 
The functional significance of any change in alternative
mRNA splicing manifests itself via the expression of a new
protein isoform. We have shown that the rapidly induced
change in alternative splicing of PMCA2 mRNAs is fol-
lowed by the faithful expression of the corresponding
protein variants. Unfortunately, understanding the func-
tional significance of isoform and splice variant diversity of
the PMCA gene family is hampered by the inability to
measure the function of the protein directly in vivo. This is
due to a lack of specific inhibitors for this pump and its low
turnover rate, rendering it unsuitable for measurements by
techniques such as patch clamp. In addition, the fact that
all cell lines we have tested so far express all four PMCA
genes (a total of six different splice variants in IMR32
1648 Current Biology 1996, Vol 6 No 12
Figure 8
Evaluation of alternative splice variant
expression by RPA. (a) 10 mg of whole RNA
from IMR32 cells grown in standard control
medium (MEM) or depolarized for 3 h in high-
KCl medium (+ KCl) was co-hybridized with
single-stranded, 32P-labeled antisense RNA
probes complementary to either the w or the x
splice variant and GAPDH, a ‘housekeeping’
gene used as a standard. After digestion, the
protected fragments were separated on a 6 %
denaturing polyacrylamide gel which was then
dried and analyzed by PhosphorImager. An
autoradiogram of the gel is shown. As found
by RT–PCR, only splice variant w is detected
in cells in their resting state (MEM); whereas
expression of variant x is apparent after KCl-
depolarization (KCl). ‘w’ and ‘x’ on the bottom
of each lane indicate the probe used together
with GAPDH in that reaction. (b)
PhosphorImager analysis of PMCA2 splice
variant expression levels standardized to
GAPDH. Upon KCl-depolarization
(IMR + KCl), the ratio of x to w dramatically
increases, and the total amount of hPMCA2
message rises about four-fold compared to
that found in control cells (IMR32 MEM).
Numbers on the ordinate are arbitrary units.
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cells) makes it difficult to assign specific functions to dif-
ferent PMCA splice variants. In cerebellar Purkinje cells,
an increased frequency of calcium ‘spikes’ generated from
an increase in synaptic excitation may require an appropri-
ate adjustment in the calcium extrusion mechanism which
may be provided by specific splice variants of PMCA2.
Changes in the electrical activity in brain and muscle cells
during development or upon repetitive use have previ-
ously been shown to alter the expression of alternative
splice variants of other important channels and cell surface
molecules, including members of the ionotropic glutamate
receptors [49] and the neural cell adhesion molecules [17].
In recent years, several examples have emerged of alterna-
tive splicing having a profound effect on the spatial distrib-
ution of the encoded protein isoforms in neuronal cells;
these examples include the localization of NMDA receptor
subunits NR1A and NR1D to the postsynaptic density
[50], and of multifunctional Ca2+/calmodulin kinase to the
nucleus [51]. Alternative splicing has also been shown to
alter interactions between proteins, such as the binding of
Neuroligin to b Neurexins [52]. Thus, it has become clear
that the inclusion or exclusion of a protein module or
domain via alternative splicing of the precursor mRNA can
have profound functional consequences for the mature
protein, a situation that is likely to apply to the alterna-
tively spliced isoforms of the PMCA2 as well. 
An increase in intracellular calcium is requisite for the
change in alternative splice variant expression that we
describe here. Direct measurements of intracellular free
calcium levels using fluo-3 imaging revealed that KCl
depolarization led to an initial, short-lasting rise in cytoso-
lic calcium followed by recovery to a baseline level which
was slightly elevated above prestimulus levels even under
chronic KCl-depolarization conditions. Remarkably, the
shift in alternative splicing was essentially ‘saturated’ after
a brief elevation of intracellular calcium — no further shift
toward a higher ratio of the x to w splice variants of
PMCA2 could be elicited when cells were exposed to high
KCl for several hours. It appears, therefore, that a new
equilibrium for alternative splicing of hPMCA2 mRNAs is
quickly established upon initial calcium signaling.
Although expression of the x variant rises gradually, start-
ing about 30–45 minutes following the initial depolariza-
tion, the level of the x splice form never significantly
exceeds that of the w form. This either indicates the pres-
ence of two different cell populations, only one of which
can undergo the splice shift, or indicates a mechanism
whereby at most 50 % of all new hPMCA2 transcripts are x-
spliced. Single-cell RT–PCR or immunocytochemical
analysis using splice form-specific antibodies will be
required to resolve this issue.
Preventing the rise in intracellular calcium by rapid,
BAPTA-mediated buffering completely abolished the
change in alternative splicing. Exactly what occurs
between the initial rise in calcium and the ‘reprogram-
ming’ of the splicing machinery has not yet been com-
pletely defined. In the KCl-depolarization model,
preapplication of the kinase inhibitor H-89 at 50 mM — a
level known to inhibit almost all major serine/threonine
kinases — blocked the change in splice variant expression
(D.A.Z., unpublished observations). This suggests that a
serine/threonine phosphorylation event is a necessary
intermediate step. In rat PC12 cells, calcium influx-
dependent neurite outgrowth was recently shown to be
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Figure 9
Western-blot analysis of hPMCA2 splice
variant expression. (a) Equal amounts of total
protein extracted from IMR32 cells grown in
standard control medium (MEM) or
depolarized for 12 h in high-KCl medium
(+ KCl) were separated by SDS–PAGE and
transblotted to a PVDF membrane. The
membrane was probed by a polyclonal rabbit
antibody specific to hPMCA2 and the signal
was detected by ECL and recorded on film.
(b) The film corresponding to the western blot
in (a) was digitized and analyzed by NIH
Image v. 1.60 (Plot Profile) as described in
Materials and methods. The presence of both
splice variants w and x in protein extracted
from cells depolarized by K+ was clearly
established (red line), whereas cells grown in
control MEM express only the w isoform
(green line). The units on the ordinate are gray
levels and those on the abscissa denote the
distance of the signal from the origin (top of
the gel).
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mediated by a cascade involving the rapid activation of
nonreceptor tyrosine kinases leading to activation of the
Ras signaling pathway [53]. Multiple, partially overlap-
ping or converging signaling pathways involving
serine/threonine as well as tyrosine kinases may thus be
activated by the calcium signal. The exact order of the
sequential interactions leading from an initial rise in
intracellular calcium to a change in alternative splicing in
the nucleus remains to be fully elucidated. Recent evi-
dence indicates that phosphorylation of several SR pro-
teins and hnRNPs is important for their function in
splicing [54,55]. Significantly, some of these phosphory-
lation events are mediated by calcium-dependent path-
ways [56]. The rapidly growing family of SR proteins
[57] constitutes the most likely source from which new
proteins that regulate splicing events will be found. It
seems feasible that some of them should be under the
direct regulatory control of second messenger signaling
pathways, such as those initiated by a rise in intracellular
calcium. 
Conclusions
Here, we show that alternative mRNA splicing in IMR32
neuroblastoma cells is directly regulated by an increase in
intracellular calcium. The observed change in expression
of alternatively spliced mRNAs for the human plasma
membrane calcium ATPase isoform 2 occurs rapidly, is
independent of new protein synthesis, and — once
induced — persists through multiple rounds of cell divi-
sion. The calcium-induced change in splicing affects only
one specific set of exons in hPMCA2 transcripts, other
alternative splice sites in hPMCA2 or other hPMCA tran-
scripts are not influenced. The signal cascade leading from
an elevation of calcium to a long-lasting change in the
machinery regulating alternative splicing is likely to
involve a serine/threonine kinase step. Proteins of the SR
family, which have been suggested to participate in alter-
native mRNA splicing, are likely downstream targets of
the signaling cascade. Western-blot data confirm that the
newly generated alternatively spliced transcripts are faith-
fully translated into the corresponding hPMCA2 isoforms.
Given the abundant expression of PMCA2 in the brain,
and its preferential localization to the dendrites and den-
dritic spines of cerebellar Purkinje cells, the calcium sig-
naling-induced expression of a new PMCA2 splice variant
may be part of the biochemical changes characteristic of
synaptic plasticity and reflect a feedback control mecha-
nism to optimize local calcium homeostasis. Elucidating
the precise pathway of the calcium-induced signaling
cascade leading to a selective change in alternative mRNA
splicing and the specific role of the newly expressed
hPMCA2 isoform in neuronal Ca2+ handling remain
important goals for the future. This rapid second messen-
ger-induced change in alternative mRNA splicing may
represent a novel mechanism to regulate gene expression
at the post-transcriptional level.
Materials and methods
Cell cultures
IMR-32 human neuroblastoma cells were obtained at passage 58 from
V. Lennon (Department of Neuroimmunology, Mayo Clinic) and were
grown on plastic culture dishes (Gibco BRL) in standard minimal
essential medium (MEM) supplemented with 1× non-essential amino
acids, 1× glutamine, 1× penicillin/streptomyocin/fungizone and 10 %
fetal bovine serum (FBS) in a humidified atmosphere at 37 °C and 5 %
CO2. All cell culture media and components were from Gibco BRL
unless otherwise stated. After the adherent cells became 65–75 %
confluent, this medium was exchanged for the identical medium without
serum. All subsequent experiments were performed on cells which had
been maintained in serum-free conditions for at least 2 days and with at
least two changes of the serum-free medium. For subculture, cells were
always split into the serum-containing medium. Experiments were per-
formed on cells at 70–90 % confluency, and experimental and control
cells were from the same passage. For studies involving measurements
of intracellular Ca2+, the cells were grown on glass coverslips.
RT–PCR experiments on high KCl-depolarized IMR-32 cells grown on
glass coverslips showed the same change in alternative splicing at site
A of hPMCA2 as when the cells were grown on plastic. 
KCl depolarization
We used a custom-made culture medium from Gibco BRL in which
NaCl was iso-osmotically exchanged for extra KCl (to a final concentra-
tion of 56 mM) in standard MEM. Following a thorough wash in PBS,
cells were incubated for various times in serum-free medium containing
56 mM KCl. After the desired time of exposure to high-KCl, the cells
were either washed in PBS and directly used for RNA and protein
extraction or returned to standard MEM until harvesting.
Thapsigargin
Thapsigargin (Calbiochem) was solubilized in ethanol at a concentra-
tion of 10 mM. Dilutions of the stock solutions were made to achieve
final working concentrations in the range of 1–10 mM. Appropriate,
parallel ethanol-only controls were included. Cells were incubated in
thapsigargin-containing, serum-free MEM for 6 h before harvesting for
RNA isolation.
4-bromo-A23187
The non-fluorescent calcium ionophore 4-bromo-A23187 (Molecular
Probes) was used to permeabilize the IMR32 cell membranes in a
Ca2+-selective manner. 4-bromo-A23187 was dissolved in DMSO at a
concentration of 1 mM. A 10–6 M final concentration of the ionophore
was achieved by adding 10 ml of the stock solution to 10 ml of MEM. 
Intracellular calcium buffering by BAPTA
BAPTA-AM is a cell-permeable, highly selective, fast chelator of
calcium and can effectively be used to buffer increases in intracellular
free calcium concentrations [58]. IMR32 cells were incubated in MEM
containing 5 mM BAPTA-AM (Molecular Probes) for 20–30 min in a
cell culture incubator. Appropriate DMSO (the vehicle for BAPTA-AM)
controls were run in parallel for each different concentration of BAPTA-
AM used. After loading the cells, the medium was replaced with high-
KCl MEM and incubation was continued for 15 min. Appropriate
parallel high-KCl-only controls were run to ensure that the Ca2+-
induced effects on PMCA expression indeed occurred in the cells not
loaded with BAPTA-AM.
Real-time confocal calcium imaging
An Odyssey XL real-time confocal system (Noran Instruments) with an
Ar-Kr laser, attached to a Nikon Diaphot, was used to visualize fluo-3-
loaded IMR32 cells. The confocal system was controlled through a
Silicon Graphics Indy workstation and manufacturer-supplied software. A
Nikon 40×/1.3 oil-immersion objective lens was used to visualize the
cells. Image size was set to 640x480 pixels and pixel area was calibrated
using a stage micrometer (0.063 mm2 per pixel). The 488 nm laser line
was used to excite fluo-3 for Ca2+ imaging, and emissions were collected
using a 515 nm long-pass filter and a high-sensitivity photomultiplier
tube. A portion of the coverslip containing at least 15–20 IMR32 cells
was selected and a region of interest (ROI) tool in the confocal software
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was used to define ROIs within the boundaries of individual cells. Each
ROI had a fixed dimension of 5 × 5 pixels (1.5 mm2). The optical section
thickness for the 40× lens was set to 1 mm by controlling the slit size on
the Odyssey system. Therefore, [Ca2+]i measurements were obtained
from a volume of 1.5 mm3. A detailed description of the methodology
used for calibration of calcium concentrations and for the calcium mea-
surements can be found in Prakash et al. [59].
RNA isolation and RT–PCR
Total RNA was extracted by the guanidium isothiocyanate procedure
from IMR32 cells by published procedures [60]. Cells were washed
twice with PBS before use. Cells were then either gently aspirated to
remove them from the plate (that is, trypsin was not required) or were
lysed directly on the plate. RT–PCR was performed on total RNA as
described [27], using random hexamer primers for first-strand cDNA
synthesis and specific primer pairs [27] flanking each alternative splice
site of each PMCA gene for subsequent PCR. In addition, primers 2-
640 (5′-CAG GAT CCC ATC GAG CAG GAA CAG-3′) and 2-1216c
(5′-TTG CCC TGC AGC ACG GAC TTC-3′) were used to amplify the
cDNA at splice site A of hPMCA2. A 10 ml aliquot of each final reac-
tion was run on 1–4 % regular agarose gels stained with ethidium
bromide. Negative (omission of Taq polymerase, primers, or template)
and positive controls (inclusion of template to produce a fragment of
known size) were included in all experiments to ensure the absence of
carryover contamination and the integrity of the PCR assay conditions.
The identity of each PCR product was established by comparison with
known standards obtained from cloned fragments corresponding to the
individual alternative splice variants [27].
Quantitative ribonuclease protection assay
RNA probes used in the analysis of alternative splicing at site A of
hPMCA2 were created as follows. 10 pmol of upstream primer 2-640
and 10 pmol of downstream primer T7/2-1216c (5′-GGA TCC TAA TAC
GAC TCA CTA TAG GGA GGT TGC CCT GCA GCA CGG ACT TC-
3′) were used in a PCR on 10 ng of cloned and sequenced hPMCA2 w
or x splice variant cDNA as template. The resulting PCR products were
650 bp (w) and 557 bp (x) in size. The PCR cycling profile was as
follows: denature at 95 °C for 3 min, then 25 cycles of 1 min at 95 °C, 1
min at 57 °C and 1 min at 72 °C. The resulting PCR products contained
the T7 RNA polymerase promoter sequence in the antisense orientation
with respect to the coding sequence of the gene. The same strategy was
used to create the internal standard template, GAPDH. The primers
GAPDH-345 (5′-ATG CTG GCG CTG AGT ACG TC-3′) and
T7/GAPDH-565c (5′-GGA TCC TAA TAC GAC TCA CTA TAG GGA
GGG GTC ATG AGT CCT TCC ACG ATA CC-3′) were located at posi-
tions 326–345 and 565–588 in the human GAPDH cDNA sequence
(GenBank accession number M33197). Again, the downstream primer,
T7/GAPDH-565c was engineered to contain the T7 RNA polymerase
promoter. A complete description of this strategy is found in the Instruc-
tion Manual for the RPAII kit (Ambion). For in vitro transcription, the reac-
tions contained the following: 2ml water, 2 ml 10× T7 reaction buffer
(containing DTT), 1 ml each 10 mM GTP, 10 mM ATP, 10 mM TTP and
0.02 mM CTP, 5 ml a-[32P]CTP (DuPont NEN; 3000 Ci mmol–1, 10 mCi
ml–1); 10 U RNAse inhibitor, 40 U T7 RNA polymerase (Boehringer) and
5 ml T7 promoter-containing PCR product described above. The reaction
mixture was incubated at 37 °C for 60 min followed by another 15 min
upon addition of 20 U DNAseI (RNAse free). This step is critical as it
removes the DNA template which would compete for the radiolabeled
probe in the subsequent hybridization reaction. After DNAse digestion of
the template, the labeled RNA probe was purified by phenol/chloroform
extraction. The specific activity of 1ml of each probe was measured in a
scintillation counter to determine the quantity to be added to each
hybridization reaction. Standard controls included probe-only (no cellular
RNA) and tRNA plus probe. The same samples of RNA used for
RT–PCR were used for Q-RPA allowing a direct comparison between
results obtained by these two methods. The assays were performed
according to the specifications provided by the manufacturer of the
RPAII kit (Ambion). Specific conditions were as follows. Hybridization: 10
mg whole RNA, 50 000 cpm probe, 43 °C for 12–18 h. RNAse
digestion: RNAse A/T1 dilution, 1:100; 37°C for 30 min. 100 ml ethanol
were added to the reaction after addition of the digestion stop buffer to
facilitate precipitation of the protected fragments. After precipitation for
30 min at –20 °C, the protected fragments were pelleted by
centrifugation at 30 000 × g for 30 min in a Beckman JA18.1 rotor, dis-
solved in the buffer provided by Ambion and separated on a 6 % urea
sequencing-format gel. After electrophoresis, the gels were dried onto
Whatmann 3MM blotting paper and exposed to the PhosphorImager
(Molecular Dynamics) Phosphor Screen overnight.
Cycloheximide inhibition of protein synthesis
IMR32 cells were preincubated for 30 min in 50mg ml–1 cycloheximide
(Sigma) followed by a 6 h exposure to 56 mM KCl-containing medium in
the continuous presence of 50mg ml–1 cycloheximide. 
Western-blot analysis
An isoform-specific, rabbit polyclonal antiserum against PMCA2 was
kindly provided by J.T. Penniston and A.G. Filoteo. To extract whole
protein, IMR32 cells from 70–80 % confluent 10 cm dishes were gently
aspirated and pelleted by centrifugation into a 15 ml conical Falcon tube.
The medium was decanted and the pellet solubilized by sonication in
PBS, 0.4 % NP-40, 1 mM EDTA, 1 mM PMSF, 10 mM leupeptin. The
cells were sonicated on ice for 45 sec to 1 min with 3 sec pulse/rest
intervals. Following sonication, the proteins were extracted on ice for
20–30 min. The resulting lysate was centrifuged at 4°C for 20–30 min
at 100 000 × g in a TLA 100 Beckman ultramicrocentrifuge. Protein con-
centrations were determined using the Pierce BCA assay as per the sup-
plied protocol. 5–10 mg aliquots of total protein were solubilized in 4×
Laemmli SDS–PAGE sample buffer [60] containing DTT and urea.
Aliquots of these proteins were electrophoretically separated on a stan-
dard 6 % SDS–polyacrylamide gel. Mini gels were run at 100–140 V
constant voltage in a bucket of ice water until a prestained 148 kDa mol-
ecular weight marker (phosphorylase b, MultiMarkTM, Novex) was within
the final 1/3 of the gel. After equilibration of the gel in transfer buffer (25
mM Tris-HCl, 160 mM glycine), proteins were transblotted at 4°C for
35–40 min at 60 V constant voltage onto a 0.2mm PVDF membrane
(BioRad). The membrane was briefly soaked in PBS and then washed at
room temperature with gentle rocking in PBS containing 5 % H2O2 and
0.02 % Na-azide (5 min), followed by 3 × 5 min in PBS. The membranes
were then blocked in PBS with 10 % (w/v) non-fat dry milk powder for
24 h at 4 °C with rocking. The unwashed membrane was transferred to
10 ml of PBS containing anti-PMCA2 antibody at a dilution of 1:1000
and incubated for at least 12 h at 4 °C with rocking. Following five
washes (5 min each) in PBS, the membrane was incubated at room tem-
perature for 2–3 h in 10 ml PBS containing a 1:20 000 dilution of the
secondary antibody (horseradish peroxidase-coupled goat anti rabbit IgG
(Tago). Final washing was for 2–6 h in PBS with at least six changes of a
large volume of PBS. The proteins of interest were detected using the
Renaissance ECL kit from DuPont NEN. The chemiluminescent signals
were recorded on Bio-Max MR film (Kodak). The resulting autolumi-
graphs were digitized as TIFF files and imported into NIH Image v.1.60
for analysis. The function used to document the existence of the x splice
variant of hPMCA 2 at splice site A was ‘Plot Profile’ which allows one to
detect variations in the signal intensity of autoradiographic films by mea-
suring the optical density of a band and reporting the results in a gray-
level format. Data produced from Plot Profile were exported to
CA-Cricket Graph 3 for plotting. 
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